These are brand-stated timelines
Recently, the development of GLP-1 agonists that show promise against obesity-associated disease named as Sciences 2023 Breakthrough ( Due to the different routes of administration and different GLP-1R analogs, GLP-1 and GLP-1R may be involved in different signaling pathways that directly or indirectly send signals to the central nervous system to inhibit ingestion and regulate eating behaviors by the nociceptors
Department of Health and Human Services (HHS), Google, Microsoft, Netflix, Bridgewater Associates, ConocoPhillips, British Petroleum, One Medical, and Jenny Craig, Inc
thus, the use of levodopa can cause symptomatic pyridoxine deficiency 56,57
Rather, it is about which mechanistic coverage your protocol requires